 | • レポートコード：MRC2301E003 • 出版社/出版日：Persistence Market Research / 2022年10月19日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料は、世界の植物由来ワクチン市場について総合的・多面的に調査しています。本資料では、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症危機分析、需要分析・予測、ソース別（トウモロコシ、タバコ、じゃがいも、その他）分析、種類別（ウイルスワクチン、細菌ワクチン、その他）分析、用途別（インフルエンザ、ジカウイルス、エボラウイルス、その他）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ）分析、構造分析、競争分析、仮定、調査方法などを整理しております。また、Creative Biolabs、Medicago Inc.、iBio、ICON、EEA Consulting Engineers、Kentucky BioProcessing, Incなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症危機分析 ・需要分析・予測 ・世界の植物由来ワクチン市場規模：ソース別 - トウモロコシ由来ワクチンの市場規模 - タバコ由来ワクチンの市場規模 - じゃがいも由来ワクチンの市場規模 - その他の市場規模 ・世界の植物由来ワクチン市場規模：種類別 - ウイルスワクチンにおける市場規模 - 細菌ワクチンにおける市場規模 - その他における市場規模 ・世界の植物由来ワクチン市場規模：用途別 - インフルエンザ用植物由来ワクチンの市場規模 - ジカウイルス用植物由来ワクチンの市場規模 - エボラウイルス用植物由来ワクチンの市場規模 - その他の市場規模 ・世界の植物由来ワクチン市場規模：地域別 - 北米の植物由来ワクチン市場規模 - 中南米の植物由来ワクチン市場規模 - ヨーロッパの植物由来ワクチン市場規模 - 東アジアの植物由来ワクチン市場規模 - 南アジアの植物由来ワクチン市場規模 - オセアニアの植物由来ワクチン市場規模 - 中東・アフリカの植物由来ワクチン市場規模 ・構造分析 ・競争分析 ・仮定 ・調査方法 |
Plant-based Vaccines Market: Scope of Report
The latest publication by Persistence Market Research on the global plant-based vaccines market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers in knowing the demand for plant-based vaccines product and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the plant-based vaccines market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the plant-based vaccines market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the plant-based vaccines market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the plant-based vaccines market offers information divided into four important segments – type, source, application, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Type
Viral Vaccines
Bacterial Vaccines
Others
Source
Maize
Tobacco
Potatoes
Others
Application
Influenza
Zika Virus
Ebola Virus
Others
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for plant-based vaccines over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the plant-based vaccines market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the plant-based vaccines market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the plant-based vaccines market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Promotional Strategies, By Key Manufacturers
4.2. Key Regulations
4.3. Product Pipeline
4.4. Reimbursement Scenario
4.5. Value Chain Analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Recombinant Vaccines Market Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Cost of Production
5.2.2. Growing Development of Recombinant Vaccines
5.2.3. Increasing Incidence of Zoonotic Diseases
5.2.4. Rising Research and Development Activities
5.2.5. Growing Marketing Approvals for Plant-Based Vaccines
5.2.6. Cost of Vaccines
5.2.7. Emergence of the COVID-19 Pandemic
5.2.8. Large Clinical Pipeline
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Source
6.1.2. By Type
6.1.3. By Application
6.1.4. By Country
6.2. 2021 Market Scenario
7. Global Plant-Based Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2012-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Plant-Based Vaccines Market Analysis 2012-2021 and Forecast 2022–2032, By Source
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Source, 2012 – 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2022 – 2032
8.3.1. Maize
8.3.2. Tobacco
8.3.3. Potato
8.3.4. Others
8.4. Market Attractiveness Analysis By Source
9. Global Plant-Based Vaccines Market Analysis 2012-2021 and Forecast 2022–2032, By Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Type , 2012 – 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022 – 2032
9.3.1. Viral Vaccine
9.3.2. Bacterial Vaccine
9.3.3. Others
9.4. Market Attractiveness Analysis By Type
10. Global Plant-Based Vaccines Market Analysis 2012-2021 and Forecast 2022–2032, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2012 – 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022 – 2032
10.3.1. Influenza
10.3.2. Zika Virus
10.3.3. Ebola Virus
10.3.4. Others
10.4. Market Attractiveness Analysis By Application
11. Global Plant-Based Vaccines Market Analysis 2012-2021 and Forecast 2022–2032, By Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Source
12.3.3. By Type
12.3.4. By Application
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Source
12.4.3. By Type
12.4.4. By Application
12.5. Market Trends
12.6. Key Market Participants – Intensity Mapping
12.7. Drivers and Restraints – Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Plant-Based Vaccines Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast By Market Taxonomy
12.8.1.2.1. By Country
12.8.1.2.2. By Source
12.8.1.2.3. By Type
12.8.1.2.4. By Application
12.8.2. Canada Plant-Based Vaccines Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast By Market Taxonomy
12.8.2.2.1. By Country
12.8.2.2.2. By Source
12.8.2.2.3. By Type
12.8.2.2.4. By Application
13. Latin America Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.1.4.1. By Country
13.3.1.4.2. By Source
13.3.1.4.3. By Type
13.3.1.4.4. By Application
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Source
13.4.3. By Type
13.4.4. By Application
13.5. Market Trends
13.6. Key Market Participants – Intensity Mapping
13.7. Drivers and Restraints – Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Plant-Based Vaccines Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast By Market Taxonomy
13.8.1.2.1. By Source
13.8.1.2.2. By Type
13.8.1.2.3. By Application
13.8.2. Brazil Plant-Based Vaccines Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast By Market Taxonomy
13.8.2.2.1. By Country
13.8.2.2.2. By Source
13.8.2.2.3. By Type
13.8.2.2.4. By Application
13.8.3. Argentina Plant-Based Vaccines Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast By Market Taxonomy
13.8.3.2.1. By Source
13.8.3.2.2. By Type
13.8.3.2.3. By Application
14. Europe Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Source
14.3.3. By Type
14.3.4. By Application
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Source
14.4.3. By Type
14.4.4. By Application
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints – Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Plant-Based Vaccines Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast By Market Taxonomy
14.8.1.2.1. By Source
14.8.1.2.2. By Type
14.8.1.2.3. By Application
14.8.2. Italy Plant-Based Vaccines Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast By Market Taxonomy
14.8.2.2.1. By Source
14.8.2.2.2. By Type
14.8.2.2.3. By Application
14.8.3. France Plant-Based Vaccines Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast By Market Taxonomy
14.8.3.2.1. By Source
14.8.3.2.2. By Type
14.8.3.2.3. By Application
14.8.4. U.K. Plant-Based Vaccines Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast By Market Taxonomy
14.8.4.2.1. By Source
14.8.4.2.2. By Type
14.8.4.2.3. By Application
14.8.5. Spain Plant-Based Vaccines Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast By Market Taxonomy
14.8.5.2.1. By Source
14.8.5.2.2. By Type
14.8.5.2.3. By Application
14.8.6. BENELUX Plant-Based Vaccines Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast By Market Taxonomy
14.8.6.2.1. By Source
14.8.6.2.2. By Type
14.8.6.2.3. By Application
14.8.7. Russia Plant-Based Vaccines Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast By Market Taxonomy
14.8.7.2.1. By Source
14.8.7.2.2. By Type
14.8.7.2.3. By Application
15. East Asia Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Source
15.3.3. By Type
15.3.4. By Application
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Source
15.4.3. By Type
15.4.4. By Application
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Plant-Based Vaccines Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast By Market Taxonomy
15.8.1.2.1. By Source
15.8.1.2.2. By Type
15.8.1.2.3. By Application
15.8.2. Japan Plant-Based Vaccines Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast By Market Taxonomy
15.8.2.2.1. By Source
15.8.2.2.2. By Type
15.8.2.2.3. By Application
15.8.3. South Korea Plant-Based Vaccines Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast By Market Taxonomy
15.8.3.2.1. By Source
15.8.3.2.2. By Type
15.8.3.2.3. By Application
16. South Asia Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Source
16.3.3. By Type
16.3.4. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Source
16.4.3. By Type
16.4.4. By Application
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints – Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Plant-Based Vaccines Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast By Market Taxonomy
16.8.1.2.1. By Source
16.8.1.2.2. By Type
16.8.1.2.3. By Application
16.8.2. Indonesia Plant-Based Vaccines Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast By Market Taxonomy
16.8.2.2.1. By Source
16.8.2.2.2. By Type
16.8.2.2.3. By Application
16.8.3. Malaysia Plant-Based Vaccines Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast By Market Taxonomy
16.8.3.2.1. By Source
16.8.3.2.2. By Type
16.8.3.2.3. By Application
16.8.4. Thailand Plant-Based Vaccines Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast By Market Taxonomy
16.8.4.2.1. By Source
16.8.4.2.2. By Type
16.8.4.2.3. By Application
17. Oceania Plant-Based Vaccines Market 2012-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Source
17.3.3. By Type
17.3.4. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Source
17.4.3. By Type
17.4.4. By Application
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Plant-Based Vaccines Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast By Market Taxonomy
17.7.1.2.1. By Source
17.7.1.2.2. By Type
17.7.1.2.3. By Application
17.7.2. New Zealand Plant-Based Vaccines Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast By Market Taxonomy
17.7.2.2.1. By Source
17.7.2.2.2. By Type
17.7.2.2.3. By Application
18. Middle East and Africa (MEA) Plant-Based Vaccines Market Analysis 2012–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012–2021
18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Source
18.3.3. By Type
18.3.4. By Application
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Source
18.4.3. By Type
18.4.4. By Application
18.5. Market Trends
18.6. Key Market Participants – Intensity Mapping
18.7. Drivers and Restraints – Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Plant-Based Vaccines Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast By Market Taxonomy
18.8.1.2.1. By Source
18.8.1.2.2. By Type
18.8.1.2.3. By Application
18.8.2. Turkey Plant-Based Vaccines Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast By Market Taxonomy
18.8.2.2.1. By Source
18.8.2.2.2. By Type
18.8.2.2.3. By Application
18.8.3. South Africa Plant-Based Vaccines Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast By Market Taxonomy
18.8.3.2.1. By Source
18.8.3.2.2. By Type
18.8.3.2.3. By Application
18.8.4. North Africa Plant-Based Vaccines Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast By Market Taxonomy
18.8.4.2.1. By Source
18.8.4.2.2. By Type
18.8.4.2.3. By Application
19. Market Structure Analysis
19.1. Market Analysis By Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis (%) of Top Players
19.4. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Creative Biolabs
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategic Overview
20.3.2. Medicago Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategic Overview
20.3.3. iBio
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategic Overview
20.3.4. ICON
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategic Overview
20.3.5. EEA Consulting Engineers
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategic Overview
20.3.6. Kentucky BioProcessing, Inc.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategic Overview
20.3.7. Baiya Phytopharm
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategic Overview
20.3.8. Protalix Biotherapeutics
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategic Overview
21. Assumptions and Acronyms Used
22. Research Methodology